DRI Healthcare Trust (DHT.UN) Competitors C$13.37 +0.10 (+0.75%) As of 07/4/2025 03:59 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesBuy This Stock DHT.UN vs. ATT, AGRA, MJ, BIO, BBM, BAMM, LOVE, CSI, CALI, and DCNNShould you be buying DRI Healthcare Trust stock or one of its competitors? The main competitors of DRI Healthcare Trust include Abattis Bioceuticals (ATT), Agraflora Organics International (AGRA), Amplify Alternative Harvest ETF (MJ), Bio-Rad Laboratories (BIO), Blueberries Medical (BBM), BooksAMillion (BAMM), Cannara Biotech (LOVE), Chemesis International (CSI), China Auto Logistics (CALI), and Digicann Ventures (DCNN). These companies are all part of the "drug manufacturers - specialty & generic" industry. DRI Healthcare Trust vs. Its Competitors Abattis Bioceuticals Agraflora Organics International Amplify Alternative Harvest ETF Bio-Rad Laboratories Blueberries Medical BooksAMillion Cannara Biotech Chemesis International China Auto Logistics Digicann Ventures DRI Healthcare Trust (TSE:DHT.UN) and Abattis Bioceuticals (CNSX:ATT) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, risk, profitability, institutional ownership, media sentiment, valuation, earnings and analyst recommendations. Which has better earnings & valuation, DHT.UN or ATT? DRI Healthcare Trust has higher revenue and earnings than Abattis Bioceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDRI Healthcare TrustC$193.66MN/AC$9.73M-C$0.05-267.40Abattis BioceuticalsN/AN/AN/AN/AN/A Do analysts recommend DHT.UN or ATT? DRI Healthcare Trust presently has a consensus price target of C$18.07, indicating a potential upside of 35.16%. Given DRI Healthcare Trust's stronger consensus rating and higher possible upside, equities research analysts plainly believe DRI Healthcare Trust is more favorable than Abattis Bioceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score DRI Healthcare Trust 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.83Abattis Bioceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media favor DHT.UN or ATT? In the previous week, DRI Healthcare Trust had 1 more articles in the media than Abattis Bioceuticals. MarketBeat recorded 1 mentions for DRI Healthcare Trust and 0 mentions for Abattis Bioceuticals. DRI Healthcare Trust's average media sentiment score of 0.00 equaled Abattis Bioceuticals'average media sentiment score. Company Overall Sentiment DRI Healthcare Trust Neutral Abattis Bioceuticals Neutral Do insiders & institutionals believe in DHT.UN or ATT? 48.4% of DRI Healthcare Trust shares are owned by institutional investors. 0.1% of DRI Healthcare Trust shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Is DHT.UN or ATT more profitable? DRI Healthcare Trust has a net margin of 5.02% compared to Abattis Bioceuticals' net margin of 0.00%. DRI Healthcare Trust's return on equity of 2.06% beat Abattis Bioceuticals' return on equity.Company Net Margins Return on Equity Return on Assets DRI Healthcare Trust5.02% 2.06% 4.22% Abattis Bioceuticals N/A N/A N/A SummaryDRI Healthcare Trust beats Abattis Bioceuticals on 10 of the 10 factors compared between the two stocks. Get DRI Healthcare Trust News Delivered to You Automatically Sign up to receive the latest news and ratings for DHT.UN and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DHT.UN vs. The Competition Export to ExcelMetricDRI Healthcare TrustDrug Manufacturers IndustryMedical SectorTSE ExchangeMarket CapN/AC$2.13BC$5.55BC$6.19BDividend Yield3.26%2.92%5.22%6.72%P/E Ratio-267.404.1827.6650.85Price / SalesN/A566.59419.211,194.54Price / CashN/A10.3536.8983.29Price / Book1.4311.628.034.69Net IncomeC$9.73MC$21.15BC$3.18BC$301.20M7 Day Performance-0.22%1.82%2.93%2.29%1 Month Performance3.16%6.41%1.72%4.22%1 Year Performance20.23%2.54%34.39%26.95% DRI Healthcare Trust Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DHT.UNDRI Healthcare Trust1.2126 of 5 starsC$13.37+0.8%C$18.07+35.2%-12.3%C$0.00C$193.66M-267.40N/AATTAbattis BioceuticalsN/AN/AN/AN/AC$0.00N/A0.00N/AGap UpAGRAAgraflora Organics InternationalN/AN/AN/AN/A$0.00N/A0.00N/AHigh Trading VolumeMJAmplify Alternative Harvest ETFN/AN/AN/AN/A$0.00N/A0.007Gap UpBIOBio-Rad LaboratoriesN/AN/AN/AN/A$0.00N/A0.008,000High Trading VolumeBBMBlueberries MedicalN/AN/AN/AN/A$0.00N/A0.008High Trading VolumeBAMMBooksAMillionN/AN/AN/AN/A$0.00N/A0.00142High Trading VolumeLOVECannara BiotechN/AN/AN/AN/A$0.00N/A0.00N/AHigh Trading VolumeCSIChemesis InternationalN/AN/AN/AN/A$0.00N/A0.00147,000Gap DownHigh Trading VolumeCALIChina Auto LogisticsN/AN/AN/AN/A$0.00N/A0.0040Gap DownHigh Trading VolumeDCNNDigicann VenturesN/AN/AN/AN/A$0.00N/A0.00N/A Related Companies and Tools Related Companies Abattis Bioceuticals Competitors Agraflora Organics International Competitors Amplify Alternative Harvest ETF Competitors Bio-Rad Laboratories Competitors Blueberries Medical Competitors BooksAMillion Competitors Cannara Biotech Competitors Chemesis International Competitors China Auto Logistics Competitors Digicann Ventures Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:DHT.UN) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored140% Yields From Stocks Like Tesla? Here's How (July 4th Special)Imagine getting a 140% dividend from your investments. Even better? It works with big names like Tesla, ...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DRI Healthcare Trust Please log in to your account or sign up in order to add this asset to your watchlist. Share DRI Healthcare Trust With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
